PROGENICS PHARMACEUTICALS INC·4

Oct 19, 10:58 AM ET

PROGENICS PHARMACEUTICALS INC 4

4 · PROGENICS PHARMACEUTICALS INC · Filed Oct 19, 2009

Insider Transaction Report

Form 4
Period: 2009-10-16
MADDON PAUL J
Chief Executive Officer/CSO10% Owner
Transactions
  • Purchase

    Common Stock

    2009-10-16$4.88/sh+18,500$90,243804,942 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $4.839 to $4.930. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

2 files
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    EDGAR SUPPORTING DOCUMENT